Characterization and Optimization of Monobody Proteins for Targeting of Polymeric Nanoparticles to Endothelial Cells
Bioconjugate Chemistry · 06.11.2026
DOI: 10.1021/acs.bioconjchem.6c00401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 06.11.2026. Verfasst von Lauren Harkins und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Yale University, New Haven, Connecticut06511, United States. Hauptthemen laut MEDLINE: Nanoparticles, Polymers, Endothelial Cells, Antibodies. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Institute of Allergy and Infectious Diseases, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The conjugation of antibodies (Abs) to nanoparticles (NPs) is often used to target NPs to specific cell populations. However, there are issues with the methods of Ab attachment to the NP, and the effectiveness of the targeting varies with different conjugation methods. Site-specific conjugation of monobody (Mb) proteins to NPs help address the effectiveness of Ab attachment by controlling the Ab orientation on the NPs to improve targeting to cells. Here, we expand upon previous work showing the effectiveness of the Mb attachment system by providing a more in-depth characterization of Mb proteins. We investigated impacts on NP stability and in vitro cell binding of protein amounts (Mb and Ab), different Mb proteins (targeting mouse immunoglobulin G1 and human intercellular adhesion molecule 2), polymeric NP types (based on polylactic acid and poly amine-co-ester), and a conjugation method optimization. The results suggest that while Mb proteins are effective in targeting NPs to cells, different Mb proteins and different polymer NPs have different binding and stability profiles, highlighting the importance of characterization when adapting the system to NPs of different chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Yale University, New Haven, Connecticut06511, United States.
- Perlmutter Cancer Center, New York University Langone Health, New York, New York10016, United States.
- Department of Medicine, New York University Grossman School of Medicine, New York, New York10016, United States.
- Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York10016, United States.
- Department of Pathology, Yale University, New Haven, Connecticut06510, United States.
- Department of Immunobiology, Yale University, New Haven, Connecticut06510, United States.
ORCID-Profile: Xianzhi Zhang, Shohei Koide, W Mark Saltzman
Förderung
- National Institute of Allergy and Infectious Diseases
- NIDDK NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Harkins, L., Solomon, A., Zhang, X., Koide, A., Koide, S., Pober, J. S., & Saltzman, W. M. (2026). Characterization and Optimization of Monobody Proteins for Targeting of Polymeric Nanoparticles to Endothelial Cells. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00401
Vancouver
Harkins L, Solomon A, Zhang X, Koide A, Koide S, Pober JS, et al. Characterization and Optimization of Monobody Proteins for Targeting of Polymeric Nanoparticles to Endothelial Cells. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00401
BibTeX
@article{Harkins2026,
author = {Harkins, Lauren and Solomon, Abigail and Zhang, Xianzhi and Koide, Akiko and Koide, Shohei and Pober, Jordan S and Saltzman, W Mark},
title = {Characterization and Optimization of Monobody Proteins for Targeting of Polymeric Nanoparticles to Endothelial Cells},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00401}
}
EUVIMED